GERM-LINE P53 MUTATION IS UNCOMMON IN PATIENTS WITH TRIPLE PRIMARY CANCERS

被引：24

作者：

SHISEKI, M

NISHIKAWA, R

YAMAMOTO, H

OCHIAI, A

SUGIMURA, H

SHITARA, N

SAMESHIMA, Y

MIZOGUCHI, H

SUGIMURA, T

YOKOTA, J

机构：

[1] NATL CANC CTR, RES INST, DIV BIOL, 1-1 TSUKIJI 5 CHOME, CHUO KU, TOKYO 104, JAPAN

[2] TOKYO WOMENS MED COLL, DEPT HEMATOL, SHINJUKU KU, TOKYO 162, JAPAN

[3] NATL CANC CTR, CHUO KU, TOKYO 104, JAPAN

[4] NATL CANC CTR, RES INST, DIV PATHOL, CHUO KU, TOKYO 104, JAPAN

[5] HAMAMATSU UNIV SCH MED, HAMAMATSU, SHIZUOKA 43131, JAPAN

[6] KOMAGOME METROPOLITAN HOSP, BUNKYO KU, TOKYO 113, JAPAN

来源：

CANCER LETTERS | 1993年 / 73卷 / 01期

关键词：

LI-FRAUMENI SYNDROME; GERM-LINE P53 MUTATION; MULTIPLE PRIMARY CANCERS; TUMOR SUPPRESSOR GENE;

D O I：

10.1016/0304-3835(93)90187-E

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We examined five patients with multiple primary cancers who had a history of three different types of primary cancers for germ-line p53 mutations. The germ-line p53 mutation was detected in a patient who conformed to the Li-Fraumeni syndrome, but not in the other four patients. The diagnosis of these four patients did not fall in the category of Li-Fraumeni syndrome. This result indicates that germ-line p53 mutations are uncommon even in patients with triple primary cancers.

引用

页码：51 / 57

页数：7

共 50 条

[21] DOMINANT-NEGATIVE EFFECT OF A GERM-LINE MUTANT P53 - A STEP FOSTERING TUMORIGENESIS
SRIVASTAVA, S
WANG, SW
TONG, YA
HAO, ZM
CHANG, EH
CANCER RESEARCH, 1993, 53 (19) : 4452 - 4455
[22] A SURVEY OF GERM-LINE AND SOMATIC P53 GENE-MUTATIONS IN PATIENTS WITH BONE AND SOFT-TISSUE SARCOMAS
TOGUCHIDA, J
YAMAGUCHI, T
HERRERA, G
BEAUCHAMP, R
YANDELL, DW
AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 458 - 458
[23] SINGLE-BASE PAIR GERM-LINE DELETION IN THE P53 GENE IN A CANCER PREDISPOSED FAMILY
HAMELIN, R
BARICHARD, F
HENRY, I
JUNIEN, C
THOMAS, G
HUMAN GENETICS, 1994, 94 (01) : 88 - 90
[24] FUNCTIONAL-STUDIES OF A GERM-LINE POLYMORPHISM AT CODON-47 WITHIN THE P53 GENE
FELLEYBOSCO, E
WESTON, A
CAWLEY, HM
BENNETT, WP
HARRIS, CC
AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 752 - 759
[25] A novel germ line p53 mutation in intron 6 in diverse childhood malignancies
Avigad, S
Barel, D
Blau, O
Malka, A
Zoldan, M
Mor, C
Fogel, M
Cohen, IJ
Stark, B
Goshen, Y
Stein, J
Zaizov, R
ONCOGENE, 1997, 14 (13) : 1541 - 1545
[26] A novel germ line p53 mutation in intron 6 in diverse childhood malignancies
Smadar Avigad
Dalit Barel
Orit Blau
Ayelet Malka
Meira Zoldan
Celia Mor
Mina Fogel
Ian J Cohen
B Stark
Y Goshen
J Stein
Rina Zaizov
Oncogene, 1997, 14 : 1541 - 1545
[27] P53 IMMUNOREACTIVITY IS UNCOMMON IN PRIMARY CUTANEOUS LYMPHOMA
MCGREGOR, JM
DUBLIN, EA
LEVISON, DA
MACDONALD, DM
SMITH, NP
WHITTAKER, S
BRITISH JOURNAL OF DERMATOLOGY, 1995, 132 (03) : 353 - 358
[28] Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers
Dilawari, A.
Cangiarella, J.
Smith, J.
Huang, A.
Downey, A.
Muggia, F.
ECANCERMEDICALSCIENCE, 2008, 2
[29] Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation
Wang, Yian
Zhang, Zhongqiu
Lu, Yan
Yao, Ruisheng
Jia, Dongmei
Wen, Weidong
LaRegina, Marie
Crist, Keith
Lubet, Ronald
You, Ming
MOLECULAR CANCER RESEARCH, 2008, 6 (01) : 99 - 109
[30] A GERM LINE MUTATION IN EXON-5 OF THE P53 GENE IN AN EXTENDED CANCER FAMILY
LAW, JC
STRONG, LC
CHIDAMBARAM, A
FERRELL, RE
CANCER RESEARCH, 1991, 51 (23) : 6385 - 6387

← 1 2 3 4 5 →